Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy

Cancer

Volumn 77, Issue 5, 1996, Pages 964-971

  Heller, Richard ^a,b,c   Jaroszeski, Mark J ^a   Glass, L Frank ^a,c   Messina, Jane L ^a,c   Rapaport, David P ^a,c   Deconti, Ronald C ^a,c   Fenske, Neil A ^a,c   Gilbert, Richard A ^b   Mir, Lluis M ^d   Reintgen, Douglas S ^a,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b University of South Florida   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

adenocarcinoma; and bleomycin; basal cell carcinoma; electrochemotherapy; electroporation; melanoma

Indexed keywords

BLEOMYCIN; CARMUSTINE; CISPLATIN; DACARBAZINE; FLUOROURACIL; ISOTRETINOIN; LOMUSTINE; TAMOXIFEN; VINCRISTINE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CELL MEMBRANE PERMEABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG PENETRATION; ELECTROCHEMOTHERAPY; FEMALE; HUMAN; MALE; MELANOMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; UREMIA;

ADENOCARCINOMA; ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CARCINOMA, BASAL CELL; CELL MEMBRANE PERMEABILITY; ELECTROPHYSIOLOGY; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION;

EID: 13344275233     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960301)77:5<964::AID-CNCR24>3.0.CO;2-0     Document Type: Article

References (32)

1. Powell KT, Morgenthaler AW, Weaver JC. Tissue electroporation: observation of reversible electrical breakdown in viable frog skin. Biophys I 1989;56:1163-71.
2. Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. PNAS 1993;90:10504-8.
3. Grasso RJ, Heller R, Cooley JC, Haller EM. Electrofusion of individual animal cells directly to intact corneal epithelial tissue. Biochim Biophys Acta 1989;980:9-14.
4. Heller R, Grasso RJ. Transfer of human membrane surface components by incorporating individual human cells into intact animal tissue by cell-tissue electrofusion in vivo. Biochim Biophys Acta 1990;1024:185-8.
5. Heller R, Gilbert R. Biological applications of cell-tissue electrofusion. In: DC Chang, BM Chassy, JA Saunders, AE Sowers, editors. Guide to electroporation and electrofusion. San Diego: Academic Press, Inc., 1992;393-410.
6. Mir LM, Banoun H, Paoletti C. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res 1988;175:15-25.
7. Orlowski S, Belehradek J Jr., Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Biochem Pharmacol 1988;37:4727-33.
8. Chang DC, Chassy BM, Saunders JA, Sowers AE, editors. Guide to electroporation and electrofusion 1992. San Diego: Academic Press, 1992.
9. Potter H. Electroporation in biology: methods, applications and instrumentation. Ann Biochem 1988;174:361-73.
10. Weaver JC. Electroporation: a general phenomenon for manipulating cells and tissues. J Cell Biochem 1993;51:426-435.
11. Mir LM, Orlowski S, Belehradek J Jr., Paoletti C. Electrochemotherapy: potentiation of antitumor effect of bleomycin by local electric pulses. Eur J Cancer 1991;27:68-72.
12. Belehradek J Jr., Orlowski S, Poddevin B, Paoletti C, Mir LM. Electrochemotherapy of spontaneous mammory tumors in mice. Eur J Cancer 1991;27:73-6.
13. Coates AS. Systemic chemotherapy for malignant melanoma. World J Surg 1992;16(2):277-81.
14. Nathanson L, Jilani S. Chemotherapy of malignant melanoma. Cancer Treat Rev 1993;19(1):17-28.
15. Yeung RS. Management of recurrent cutaneous melanoma. Curr Probl Cancer 1994;18(3):143-86.
16. Buzaid AC, Murren J. Chemotherapy for advanced malignant melanoma. Int J Clin Lab Res 1992;21(3):205-9.
17. Okino M, Marumoto M, Kanesada H, Kuga K, Mohri H. Electrical impulse chemotherapy for rat solid tumors. Proc Jpn Cancer Congress 1087;46:420.
18. Okino M, Esato K. The effects of a single high voltage electrical stimulation with anticancer drug on in vivo growing malignant tumors. Jpn J Surgery 1990;20:197-204.
19. Okino M, Tomie H, Kanesada H, Marumoto M, Morita N, Esato K, et al. Induction of tumor specific selective toxicity in electrical impulse chemotherapy-analysis of dose response curve. Oncologia 1991;24:71-9.
20. Okino M, Tomie H, Kanesada H, Marumoto M, Esato K, Suzuki H. Optimal electric conditions in electrical impulse chemotherapy. Jpn J Cancer Res 1992;83:1095-1101.
21. Kanesada H. Anticancer effect of high voltage pulses combined with concentration dependent anticancer drugs on Lewis lung carcinoma. J Jpn Soc Cancer Ther 1990;25:2640-8.
22. Salford LG, Persson BRR, Brun A, Ceberg CP, Kongstad PCh, Mir LM. A new brain tumor therapy combining bleomycin with in vivo electropermeabilization. Biochern Biophys Res Comm 1993;194(2):938-43.
23. Heller R, Jaroszeski M, Leo-Messina J, Perrott R, Van Voorhis N, Reinigen D, et al. Treatment of B16 melanoma with the combination of electroporation and chemotherapy. Bioelectrochem Bioenerget 1995;36:83-7.
24. Sersa G, Cemazar M, Miklavcic D, Mir LM. Electrochemotherapy: variable anti-tumor effect on different tumor models. Bioelectrochem Bioenerget 1994;35:23-7.
25. Yamaguchi O, Irisawa C, Baba K, Ogihara M, YokotaT, Shiraiwa Y. Potentiation of antitumor effect of bleomycin by local electric pulses in mouse bladder tumor. Tohoku J Exp Med 1994;172:291-3.
26. Dev SB, Hofmann GA. Electrochemotherapy-a novel method of cancer treatment. Cancer Treat Rev 1994;20:105-15.
27. Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin J Jr., Schwab G, et al. Electrochemotherapy, a novel antitumor treatment: first clinical trial. CR Acad Sci Paris 1991;313:613-8.
28. Belehradek M, Domenge C, Luboinnski B, Orlowski S, Belehradek J, Mir LM. Electrochemotherapy, a new antitumor treatment first clinical phase I-II trial. Cancer 1993;72(12):3694-700.
29. Auerbach R, Morrissey LW. Sidky YA. Regional differences in the incidence and growth of mouse tumors following intradermal or subcutaneous inoculation. Cancer Res 1978;38:1739-44.
30. Mir LM, Orlowski S, Poddevin B, Belehradek J Jr. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw 1992;3:331-4.
31. Mir LM, Roth C, Orlowski S, Belehradek J Jr., Fradelizi F, Paoletti C, et al. Potentiation of the antitumoral effect of electrochemotherapy by an immunotherapy with allogeneic cells producing interleukin-2. CR Acad Sci Paris 1992;314:539-44.
32. Mir LM, Roth C, Orlowski S, Quintin-Colonna F, Fradelizi F, Belehradek J Jr., et al. Systemic antitumor effects of electrochemotherapy combined with histocompatible cells secreting interleukin-2. J Immun 1995;17:30-8.